![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
A SWITCH TO DOLUTEGRAVIR IN COMBINATION WITH BOOSTED DARUNAVIR IS SAFE AND
EFFECTIVE IN SUPPRESSED PATIENTS WITH HIV - A SUBANALYSIS OF THE DUALIS STUDY
|
|
|
Reported by Jules Levin
10th IAS Conference on HIV Science (IAS 2019), July 21-24, 2019, Mexico City
![0801191](../images/080119/080119-10/0801191.gif)
![0801192](../images/080119/080119-10/0801192.gif)
![0801193](../images/080119/080119-10/0801193.gif)
![0801194](../images/080119/080119-10/0801194.gif)
![0801195](../images/080119/080119-10/0801195.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|